Metraipolis › archive › dc_df106788ebd4

Survival Outcomes Following Yttrium-90 and Holmium-166 Transarterial Radioembolization for Hepatocellular Carcinoma — Europe PMC PMID:42449586

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42449586
DOI
10.3390/cancers18132039
License (as archived)
solo-consultazione
Archived
2026-10-19T04:14:27.699Z
SHA-256 of the archived text
e3a5c2f6ef2cac1ffb449416ba9c4cf9820fe92e61f528cee4588369b303da44
Stable URL of this page
https://metraipolis.com/documento/dc_df106788ebd4

How to cite

Survival Outcomes Following Yttrium-90 and Holmium-166 Transarterial Radioembolization for Hepatocellular Carcinoma — Europe PMC PMID:42449586 — Europe PMC (en), https://europepmc.org/article/MED/42449586 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df106788ebd4 (Metraipolis archive dc_df106788ebd4, sha256 e3a5c2f6ef2cac1ffb449416ba9c4cf9820fe92e61f528cee4588369b303da44)
BibTeX
@misc{dcdf106788ebd4,
  title = {Survival Outcomes Following Yttrium-90 and Holmium-166 Transarterial Radioembolization for Hepatocellular Carcinoma — Europe PMC PMID:42449586},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42449586},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df106788ebd4; sha256 e3a5c2f6ef2cac1ffb449416ba9c4cf9820fe92e61f528cee4588369b303da44},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42449586. Agents can read the archived copy with the MCP tool read_document.